Search results for: Kenneth Arrow
Filter search results
Industrial Policy and the Pharmaceutical Industry
1 January 1995
…European Community, Japan and the US are by Yarrow, and Professors Neary and Scherer, respectively. In the fourth paper Hale and Towse assess how valuable the UK-based pharmaceutical industry is…
Controlling NHS Expenditure: The Impact of Labour’s NHS White Papers
1 December 1998
…and other public expenditure programmes (social security, education, defence, and so on). From a narrow health service viewpoint, any unplanned additional expenditure may not have gone where the NHS would,…
OHE’s Adrian Towse to Take Office as ISPOR President
3 June 2014
…information, economic analysis and outcomes research. ISPOR must lead the scientific developments necessary to respond to these needs. We must break out of the narrow perspective of focussing on very…
Benchmarking and Incentives in the NHS
5 January 2000
…total effort. Successful agencies pursue narrow and clear missions. This suggests a limited number of benchmarks should be set for each type of organisation within the NHS, with different benchmarks…
Consolidation and Competition in the Pharmaceutical Industry
9 January 2001
…becoming a key policy issue alongside the traditional concern with competition between existing products in final markets. Yarrow makes another key point, which is that the need for the additional…
Why Care About Health Inequality?
1 January 2001
…illness; to improve the health of the worst off in society and to narrow the health gap. This monograph looks at health inequalities in the UK from a health economics…
Around The World in HTAs: Spain – Are We There Yet?
15 March 2023
…the CIPM. Current challenges The standard process to evaluate pharmaceutical products gives a narrow time window of 10 days for REvalMed to conduct the economic evaluation of the new drug,…